|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 327.43 USD | +0.97% |
|
-4.08% | +0.12% |
| 04:47pm | Honeywell Says Quantinuum Plans Confidential Filing of IPO Draft Registration | MT |
| 01-13 | Ro partners with Amgen to study barriers to obesity care, GLP-1 access | RE |
| Capitalization | 175B 150B 140B 130B 242B 15,765B 261B 1,604B 631B 7,541B 655B 641B 27,633B | P/E ratio 2025 * |
25.4x | P/E ratio 2026 * | 24.1x |
|---|---|---|---|---|---|
| Enterprise value | 219B 188B 175B 163B 304B 19,785B 328B 2,013B 792B 9,464B 822B 805B 34,680B | EV / Sales 2025 * |
6.03x | EV / Sales 2026 * | 5.79x |
| Free-Float |
99.85% | Yield 2025 * |
2.95% | Yield 2026 * | 3.09% |
Last Transcript: Amgen Inc.
| 1 day | +0.95% | ||
| 1 week | -4.08% | ||
| Current month | +0.12% | ||
| 1 month | +0.73% | ||
| 3 months | +11.52% | ||
| 6 months | +10.32% | ||
| Current year | +0.12% |
| 1 week | 319.78 |  | 341.46 |
| 1 month | 318.21 | | 343.05 |
| Current year | 318.21 | | 343.05 |
| 1 year | 261.43 | | 346.38 |
| 3 years | 211.71 | | 346.85 |
| 5 years | 198.64 | | 346.85 |
| 10 years | 133.64 | | 346.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CEO | Chief Executive Officer | 63 | 01/05/2012 |
Peter Griffith
DFI | Director of Finance/CFO | 67 | 01/01/2020 |
Esteban Santos
COO | Chief Operating Officer | 59 | 25/07/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Charles Holley
BRD | Director/Board Member | 69 | 03/02/2017 |
Ellen Kullman
BRD | Director/Board Member | 70 | 14/10/2016 |
Robert Eckert
BRD | Director/Board Member | 71 | 01/01/2012 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +3.57% | 5.08% | 135 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.97% | -4.08% | +22.69% | +21.63% | 175B | |
| -0.78% | -3.78% | +43.13% | +198.04% | 964B | |
| +2.12% | +5.03% | +50.56% | +26.44% | 515B | |
| +0.10% | -5.51% | +25.65% | +44.32% | 390B | |
| +0.94% | +1.74% | +30.64% | +16.80% | 363B | |
| +2.41% | +0.86% | +34.96% | +22.87% | 292B | |
| +2.13% | +2.17% | +28.80% | +34.61% | 272B | |
| +1.80% | +1.57% | +10.69% | -0.14% | 269B | |
| -1.32% | +3.23% | -36.14% | -20.59% | 265B | |
| +1.42% | -0.68% | +35.72% | +44.60% | 151B | |
| Average | +0.89% | +1.25% | +24.67% | +38.86% | 365.61B | |
| Weighted average by Cap. | +0.63% | +1.51% | +29.93% | +68.14% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 36.32B 31.16B 29.01B 27B 50.39B 3,278B 54.32B 334B 131B 1,568B 136B 133B 5,747B | 36.93B 31.69B 29.5B 27.46B 51.23B 3,334B 55.23B 339B 133B 1,595B 138B 136B 5,843B |
| Net income | 6.98B 5.99B 5.58B 5.19B 9.69B 630B 10.44B 64.15B 25.24B 302B 26.19B 25.65B 1,105B | 7.01B 6.01B 5.6B 5.21B 9.73B 633B 10.48B 64.39B 25.33B 303B 26.29B 25.75B 1,109B |
| Net Debt | 44.53B 38.21B 35.58B 33.11B 61.79B 4,020B 66.61B 409B 161B 1,923B 167B 164B 7,047B | 39.18B 33.62B 31.31B 29.13B 54.37B 3,537B 58.61B 360B 142B 1,692B 147B 144B 6,200B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/01/26 | 327.69 $ | +1.05% | 691,423 |
| 13/01/26 | 324.30 $ | -0.38% | 2,382,206 |
| 12/01/26 | 325.54 $ | -0.17% | 2,460,632 |
| 09/01/26 | 326.10 $ | -1.21% | 2,118,681 |
| 08/01/26 | 330.11 $ | -3.37% | 2,799,481 |
Delayed Quote Nasdaq, January 14, 2026 at 11:15 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- AMGN Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition